{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:17:33Z","timestamp":1753877853050,"version":"3.41.2"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The aims were to identify all incident adult cases of systemic autoimmune myopathies (SAMs) in the city of Leeds, UK, and to estimate the risk of cancer in SAMs as compared with the general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Cases of SAMs were ascertained by review of all muscle biopsy reports from the Neuropathology Laboratory. A review of medical records was undertaken for each case to review the clinical diagnosis and collect epidemiological data such as age, ethnicity, sex and comorbidities, including cancer. Leeds denominator population numbers were publicly obtainable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 206 biopsy reports were identified and, after review, 50 incident cases were included in the study between June 2010 and January 2021. Of the 50 cases, 27 were male and 23 were female. The mean incidence rate of SAMs in Leeds throughout the study period was 7.42\/1\u200a000\u200a000 person-years. The proportion of SAMs cases with a confirmed malignancy was 22%. Compared with the general population, the relative risk of cancer was significantly greater in the SAMs population (31.56; P\u2009&amp;lt;\u20090.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The incidence rate of SAMs in Leeds was consistent with data from previous literature; however, disagreement exists between different methods of SAMs case inclusion due to varying clinical criteria and definitions. SAMs are associated with an increased risk of cancer, but the pathogenesis of this relationship still requires investigating. This study supports the practice of malignancy screening and long-term surveillance in patients with SAMs.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rap\/rkac023","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T15:40:23Z","timestamp":1648568423000},"source":"Crossref","is-referenced-by-count":0,"title":["Incidence of systemic autoimmune myopathies and their risk of cancer in Leeds, UK: an 11-year epidemiological study"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2527-2112","authenticated-orcid":false,"given":"Benoit","family":"Jauniaux","sequence":"first","affiliation":[{"name":"School of Medicine, University of Leeds"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Memie","family":"Alexander","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Leeds"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azzam","family":"Ismail","sequence":"additional","affiliation":[{"name":"Department of Histopathology, St James\u2019s University Hospital, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"2022042207430968800_rkac023-B1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMc1506827","article-title":"Inflammatory muscle diseases","volume":"373","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"key":"2022042207430968800_rkac023-B2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis: a systematic review and meta-analysis","volume":"21","author":"Qiang","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"2022042207430968800_rkac023-B3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/13497413.2018.1481571","article-title":"Myositis an evolving spectrum of disease","volume":"41","author":"Barsotti","year":"2018","journal-title":"Immunol Med"},{"key":"2022042207430968800_rkac023-B4","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s10067-019-04512-6","article-title":"Comparison of the 2017 EULAR\/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies","volume":"38","author":"Pinto","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2022042207430968800_rkac023-B5","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022042207430968800_rkac023-B6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/rheumatology\/kew503","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study","volume":"56","author":"Svensson","year":"2017","journal-title":"Rheumatology (Oxford)"},{"author":"MedlinePlus","key":"2022042207430968800_rkac023-B7"},{"key":"2022042207430968800_rkac023-B8","doi-asserted-by":"crossref","first-page":"rky035","DOI":"10.1093\/rap\/rky035","article-title":"Increasing incidence of adult idiopathic inflammatory myopathies in the city of Salford, UK: a 10-year epidemiological study","volume":"2","author":"Parker","year":"2018","journal-title":"Rheumatol Adv Pract"},{"key":"2022042207430968800_rkac023-B9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/s10165-010-0362-y","article-title":"Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis","volume":"21","author":"Azuma","year":"2011","journal-title":"Mod Rheumatol"},{"key":"2022042207430968800_rkac023-B10","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar2987","article-title":"Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan","volume":"12","author":"Chen","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2022042207430968800_rkac023-B11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"2022042207430968800_rkac023-B12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaad.2020.02.061","article-title":"Malignancy in dermatomyositis: a retrospective study of 201 patients seen at the University of Pennsylvania","volume":"83","author":"Bowerman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2022042207430968800_rkac023-B13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.semarthrit.2015.06.005","article-title":"Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort","volume":"45","author":"Dobloug","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2022042207430968800_rkac023-B14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","article-title":"Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study","volume":"161","author":"Huang","year":"2009","journal-title":"Br J Dermatol"},{"key":"2022042207430968800_rkac023-B15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","article-title":"The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis","volume":"33","author":"Limaye","year":"2013","journal-title":"Rheumatol Int"},{"key":"2022042207430968800_rkac023-B16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br J Cancer"},{"key":"2022042207430968800_rkac023-B17","first-page":"5960","article-title":"Characteristics and predictors of malignancy in dermatomyositis: analysis of 239 patients from northern China","volume":"16","author":"Liu","year":"2018","journal-title":"Oncol Lett"},{"key":"2022042207430968800_rkac023-B18","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","article-title":"Tumor antigen markers for the detection of solid cancers in inflammatory myopathies","volume":"14","author":"Amoura","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022042207430968800_rkac023-B19","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy: a population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"2022042207430968800_rkac023-B20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2022042207430968800_rkac023-B21","first-page":"1094","article-title":"Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering","volume":"26","author":"Patrick","year":"1999","journal-title":"J Rheumatol"},{"key":"2022042207430968800_rkac023-B22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/03009749709115827","article-title":"Occurrence of polymyositis in the county of Gavleborg, Sweden","volume":"26","author":"Weitoft","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"2022042207430968800_rkac023-B23","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","article-title":"Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort","volume":"74","author":"Dobloug","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022042207430968800_rkac023-B24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1756-185X.2011.01669.x","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases","volume":"16","author":"Tan","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"2022042207430968800_rkac023-B25","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","article-title":"A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","volume":"60","author":"Oldroyd","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2022042207430968800_rkac023-B26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg","year":"2016","journal-title":"J Intern Med"},{"key":"2022042207430968800_rkac023-B27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"2022042207430968800_rkac023-B28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3349\/ymj.2021.62.5.424","article-title":"Comparison of the 2017 EULAR\/ACR criteria with clinicoserologic criteria for the classification of idiopathic inflammatory myopathies in Korean patients","volume":"62","author":"Chung","year":"2021","journal-title":"Yonsei Med J"},{"key":"2022042207430968800_rkac023-B29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.47102\/annals-acadmedsg.V39N11p843","article-title":"An 11-year review of dermatomyositis in Asian patients","volume":"39","author":"Liu","year":"2010","journal-title":"Ann Acad Med Singapore"},{"key":"2022042207430968800_rkac023-B30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"2022042207430968800_rkac023-B31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2009.05119.x","article-title":"Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis","volume":"1184","author":"Mammen","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2022042207430968800_rkac023-B32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","article-title":"Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria","volume":"28","author":"Mastaglia","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"2022042207430968800_rkac023-B33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","article-title":"Classification criteria for the idiopathic inflammatory myopathies","volume":"9","author":"Targoff","year":"1997","journal-title":"Curr Opin Rheumatol"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkac023\/43110721\/rkac023.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/6\/1\/rkac023\/43408329\/rkac023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/6\/1\/rkac023\/43408329\/rkac023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T19:33:48Z","timestamp":1675107228000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkac023\/6555016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkac023","relation":{},"ISSN":["2514-1775"],"issn-type":[{"type":"electronic","value":"2514-1775"}],"subject":[],"published-other":{"date-parts":[[2022]]},"published":{"date-parts":[[2022]]},"article-number":"rkac023"}}